In this interview with Alessandra Renieri we hear about the GEN-COVID network in Italy working to dsicover the genetic variability in COVID-19 patients who show phenotypic differences and what this means for treating the disease.
Researchers at the University of Toronto have revealed the binding action of the bacterial toxin responsible for toxic shock syndrome. Although similar to the toxin that causes diarrhea, the two proteins behave differently due to a short amino acid sequence, which the researchers were able to manipulate.
Take a peek behind the scenes of a recent article published by Future Virology, titled ‘Pros…
Scientists have investigated the genetic variation in immunity against seven viruses including the SARS-COV-2. The results reveal some HLA variants that may provide the most effective immune response to the viruses.
Novel research suggests that some drugs may prevent the acquisition of resistance genes by preventing the induction of bacterial ‘competence’.
Take a look a this overview of precision medicine; the concept, benefits, road blocks and what the future might hold.
Optimizing vaccine models for Streptococcus pneumoniae suggests that vaccine programs need to be tailored to target specific subgroups including age and geographical region.
A new study in The Lancet has suggested that the novel coronavirus was most genetically similar to two SARS-like coronaviruses of bat origin, but that there may be the possibility of another animal host acting as an intermediate host between bats and humans.
Scientists have synthetically engineered mosquitoes to prevent transmission of dengue virus to humans. This potentially could lead to genetic approaches to controlling the spread of dengue virus among populations.
A team from the University of California, San Diego have created a new CRISPR editing system that can effectively target antibiotic resistance genes. The system is based on a positive feedback loop and has numerous potential applications, such as treating chronic bacterial infections.
